COVID-19: Hoch dosierte Einmalgabe von Vitamin D ohne prognostischen Vorteil

Die Idee war bestechend: Könnte Vitamin D, dessen immunmodulatorisches Potenzial bei respiratorischen Erkrankungen inzwischen gut bekannt ist, die Prognose von COVID-19-Patienten verbessern? Leider wurden die Hoffnungen nicht bestätigt, wie jetzt eine randomisierte Studie aus Brasilien zeigte.

Publication History

Article published online:
16 June 2021

• Literatur

• 1 Chowdhury R, Kunutsor S, Vitezova A. et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 2014; 348: g1903
• 2 Niedermaier T, Gredner T, Kuznia S. et al. Vitamin D supplementation to the older adult population in Germany has the cost-saving potential of preventing almost 30 000 cancer deaths per year. Molecular Oncol 2021;
• 3 Peng L, Li L, Wang P. et al. Association between Vitamin D supplementation and mortality in critically ill patients: A systematic review and meta-analysis of randomized clinical trials. PLoS ONE 2020; 15: e0243768
• 4 The National Heart, Lung, and Blood Institute PETAL Clinical Trials Network. Early High-Dose Vitamin D 3 for Critically Ill, Vitamin D-Deficient Patients. N Engl J Med 2019; 381: 2529-2540
• 5 Barazzoni R, Bischoff SC, Breda J. et al. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin Nutr 2020; 39: 1631-1638
• 6 Rouget A, Vardon-Bounes F, Lorber P. et al. Prevalence of malnutrition in coronavirus disease 19: the NUTRICOV study. Br J Nutr 2020;
• 7 Li T, Zhang Y, Gong C. et al. Prevalence of malnutrition and analysis of related factors in elderly patients with COVID-19 in Wuhan, China. Eur J Clin Nutr 2020; 74: 871-875
• 8 Gehring N, Imoberdorf R, Wegmann M. et al. Serumalbumin – a qualified parameter to determine the nutritional status?. Swiss Med Wkly 2006; 136: 664-669